i3 Verticals, Inc. – Loan Agreement and Omnibus Amendment to Loan Documents (May 25th, 2018)

This Third Amendment to First Amended and Restated Loan Agreement and Omnibus Amendment to Loan Documents (this "Amendment") is entered into as of August 11, 2015, by i3 VERTICALS, LLC ("i3"), a Delaware limited liability company; CP-TOPS, LLC ("CP-TOPS"), a Delaware limited liability company; CP-USDC, LLC ("CP-USDC"), a Delaware limited liability company; CP-PS, LLC ("CP-PS"), a Delaware limited liability company; CP-APS, LLC ("CP-APS"), a Delaware limited liability company; CP-DBS, LLC ("CP-DBS"), a Delaware limited liability company, i3 VERTICALS MANAGEMENT SERVICES, INC. ("i3 Management"), a Delaware corporation, i3-RS, LLC ("i3-RS"), a Delaware limited liability company, i3-EZPAY, LLC, a Delaware limited liability company ("i3-EZ"), i3-LL, LLC, a Delaware limited liability company ("i3-LL"), i3-PBS, LLC, a Delaware limited liability company ("i3-PBS"), and i3-Infin, LLC, a Delaware limited liability company ("i3-Infin") (i3, CP-TOPS, CP-USDC, CP-PS, CP-APS, CP-DBS, i3 Management,

AVROBIO, Inc. – Certain Confidential Portions of This Exhibit Were Omitted and Replaced With [***]. A Complete Version of This Exhibit Has Been Filed Separately With the Secretary of the Securities and Exchange Commission Pursuant to an Application Requesting Confidential Treatment Pursuant to Rule 406 Promulgated Under the Securities Act of 1933, as Amended. License Agreement (May 25th, 2018)

A. BioMarin owns and/or controls certain patents and know-how pertaining to a fusion of a portion of the insulin-like growth factor 2 protein (the GILT Tag) with acid alpha-glucosidase and its use in the treatment of Pompe disease.

Essential Properties Realty Trust, Inc. – SCF RC FUNDING I LLC, as an Issuer, SCF RC FUNDING II LLC, as an Issuer, and CITIBANK, N.A., as Indenture Trustee AMENDED AND RESTATED SERIES 2016-1 SUPPLEMENT Dated as of July 11, 2017 to MASTER INDENTURE Dated as of December 7, 2016 NET-LEASE MORTGAGE NOTES, SERIES 2016-1, CLASS a AND CLASS B (May 25th, 2018)

AMENDED AND RESTATED SERIES 2016-1 SUPPLEMENT, dated as of July 11, 2017 (the Series 2016-1 Supplement), among SCF RC FUNDING I LLC, SCF RC FUNDING II LLC (each an Issuer and together, the Issuers) and the Indenture Trustee.

, as Warrant Agent FORM OF DEBT SECURITIES WARRANT AGREEMENT Dated as Of (May 25th, 2018)

DEBT SECURITIES WARRANT AGREEMENT (this "Agreement"), dated as of between VICAL INCORPORATED, a Delaware corporation (the "Company") and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the "Warrant Agent").

Subscription Agreement (May 25th, 2018)

THIS SUBSCRIPTION AGREEMENT ("SUBSCRIPTION AGREEMENT") RELATES TO A PRIVATE OFFERING OF SECURITIES IN AN OFFSHORE TRANSACTION TO PERSONS WHO ARE NOT U.S. PERSONS PURSUANT TO REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "1933 ACT").

Wintrust Financial Corporation – Amended and Restated Wintrust Financial Corporation Employee Stock Purchase Plan (May 25th, 2018)

NASDAQ, INC. EQUITY INCENTIVE PLAN (As Amended and Restated April 24, 2018) (May 25th, 2018)

Acxiom – C O N F I D E N T I a L (May 25th, 2018)

As Acxiom explores strategic options for Acxiom Marketing Solutions (AMS), the consideration described below is being offered to you as a senior executive at Acxiom and a leader of the AMS business in exchange for your support and assistance throughout a potential sale of AMS and post-transaction integration process. The terms described herein are effective immediately and shall not be amended except in writing.

CREDIT AGREEMENT Among WILLIAM LYON HOMES, INC., as Borrower, WILLIAM LYON HOMES, as Parent, THE LENDERS FROM TIME TO TIME PARTY HERETO, and JPMORGAN CHASE BANK, N.A., as Administrative Agent Dated as of May 21, 2018 JPMORGAN CHASE BANK, N.A., CITIBANK, N.A., CREDIT SUISSE SECURITIES (USA) LLC, And (May 25th, 2018)

CREDIT AGREEMENT (this Agreement) dated as of May 21, 2018, among WILLIAM LYON HOMES, INC., a California corporation (the Borrower), WILLIAM LYON HOMES, a Delaware corporation (Parent), the lenders from time to time party hereto (the Lenders) and JPMORGAN CHASE BANK, N.A., as Administrative Agent (as hereinafter defined).

CION Investment Corp – Third Amendment to Amended and Restated Loan Agreement (May 25th, 2018)

This Third Amendment to the Amended and Restated Loan Agreement (this "Amendment"), dated as of May 23, 2018, is entered into by and among 34TH STREET FUNDING, LLC (the "Company"), JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, as lender (the "Lender") and administrative agent (the "Administrative Agent"), U.S. BANK NATIONAL ASSOCIATION, as collateral agent (in such capacity, the "Collateral Agent"), collateral administrator (in such capacity, the "Collateral Administrator") and securities intermediary (in such capacity, the "Securities Intermediary") and CION investment management, llc, as portfolio manager (the "Portfolio Manager"). Reference is hereby made to the Amended and Restated Loan Agreement, dated as of September 30, 2016 (as amended by the Amendment to Amended and Restated Loan Agreement dated as of July 10, 2017 ("Amendment 1") and the Second Amendment to Amended and Restated Loan Agreement, dated as of November 28, 2017 ("Amendment 2") and as further amended or modified from

Smart Energy Solutions Inc – License Agreement (May 25th, 2018)

YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD., of Hi Tech Park, Edmond J. Safra Campus, Givat Ram, Jerusalem 91390, Israel ("Yissum"), of the first part; and CANNA POWDER LTD, of 20 Raul Wallenberg, Tel Aviv, Israel (the "Company"), of the second part; (each of Yissum and the Company, a "Party", and collectively the "Parties")

American Liberty Petroleum Corp. – Avant Diagnostics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Preferred Stock Pursuant to Section 78.1955 of the Nevada Revised Statutes (May 25th, 2018)

American Liberty Petroleum Corp. – Avant Diagnostics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Preferred Stock Pursuant to Section 78.1955 of the Nevada Revised Statutes (May 25th, 2018)

i3 Verticals, Inc. – Loan Agreement and Omnibus Amendment to Loan Documents (May 25th, 2018)

This Tenth Amendment to First Amended and Restated Loan Agreement and Omnibus Amendment to Loan Documents (this "Amendment'') is entered into as of August 1, 2017, by i3 VERTICALS, LLC ("i3"), a Delaware limited liability company; CP-PS, LLC ("CP-PS"), a Delaware limited liability company; CP-DBS, LLC ("CP-DBS"), a Delaware limited liability company, i3 VERTICALS MANAGEMENT SERVICES, INC. ("i3 Management"), a Delaware corporation, i3-RS, LLC ("i3-RS"), a Delaware limited liability company, i3-EZPAY, LLC, a Delaware limited liability company ("i3-EZ"), i3-LL, LLC, a Delaware limited liability company ("i3-LL"), i3-PBS, LLC, a Delaware limited liability company ("i3-PBS"), i3-INFIN, LLC, a Delaware limited liability company ("i3-Infin"), i3-BP, LLC, a Delaware limited liability company ("i3-BP"), i3-Axia, LLC, a Delaware limited liability company ("i3-Axia"), i3-Randall, LLC, a Delaware limited liability company ("i3-Randall"), i3-CSC, LLC, a Delaware limited liability company ("i3-CSC")

i3 Verticals, Inc. – SECOND AMENDMENT TO I3 VERTICALS, LLC AMENDED AND RESTATED EQUITY INCENTIVE PLAN (May 25th, 2018)

This Second Amendment (this "Second Amendment") to the i3 Verticals Amended and Restated Equity Incentive Plan (the "Plan"), dated as of May 7, 2018, and effective as of the Effective Date (as defined below), is adopted by i3 Verticals, LLC, a Delaware limited liability company (the "Company"). All capitalized terms used but not defined in this Second Amendment shall have the meanings ascribed to such terms in the Plan.

Exantas Capital Corp. (May 25th, 2018)

AVROBIO, Inc. – Avrobio, Inc. Amended and Restated 2015 Stock Option and Grant Plan (May 25th, 2018)

The name of the plan is the AvroBio, Inc. Amended and Restated 2015 Stock Option and Grant Plan (the Plan). The purpose of the Plan is to encourage and enable the officers, employees, directors, Consultants and other key persons of AvroBio, Inc., a Delaware corporation (including any successor entity, the Company) and its Subsidiaries, upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its business, to acquire a proprietary interest in the Company.

Eidos Therapeutics, Inc. – December 6, 2017 Christine Siu via Email Dear Christine, Eidos Therapeutics, Inc. (The Company) Is Pleased to Offer You Employment on the Following Terms: (May 25th, 2018)

Securities Purchase Agreement (May 25th, 2018)

THIS SECURITIES PURCHASE AGREEMENT (the "Agreement") is made as of the May 23, 2018 by and between MGT Capital Investments, Inc., a Delaware corporation (the "Company"), and GEMINI SPECIAL OPPORTUNITIES FUND, LP, a Delaware limited partnership, and Black Mountain Equities, Inc., a California company (collectively, the "Investors").

DEPOSIT AGREEMENT (Class B) Dated as of May 23, 2018 Between U.S. BANK NATIONAL ASSOCIATION as Escrow Agent and CITIBANK, N.A. As Depositary (May 25th, 2018)

DEPOSIT AGREEMENT (Class B) dated as of May 23, 2018 (as amended, modified or supplemented from time to time, this Agreement) between U.S. BANK NATIONAL ASSOCIATION, a national banking association, as Escrow Agent under the Escrow and Paying Agent Agreement referred to below (in such capacity, together with its successors in such capacity, the Escrow Agent), and Citibank, N.A., a national banking association, as depositary bank (the Depositary).

Acxiom – Amended and Restated Employment Agreement (May 25th, 2018)

THIS EMPLOYMENT AGREEMENT, originally dated as of July 26, 2014, (the "Agreement"), by and between Acxiom Corporation, a Delaware corporation (the "Company") and Scott E. Howe (the "Executive"), is hereby amended and restated as of February 14, 2018 (the "Restatement Date").

Sportsman'S Warehouse Holdings, Inc. – Amended and Restated Guaranty (May 25th, 2018)

WHEREAS, reference is made to that certain Credit Agreement, dated as of the date hereof (as amended and in effect immediately prior to the date hereof, the "Existing Credit Agreement"), by and among (i) Sportsman's Warehouse, Inc., a Utah corporation, as representative for the borrowers from time to time party thereto, (ii) such borrowers, (iii) the Guarantor, (iv) the lenders from time to time party thereto, and (v) Wells Fargo Bank, National Association (as successor by merger to Wells Fargo Retail Finance, LLC), as Administrative Agent, Collateral Agent and Swing Line Lender.

Securities Purchase Agreement (May 25th, 2018)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of May 22, 2018, by and between NANOFLEX POWER CORPORATION, a Florida corporation, with headquarters located at 17207 N. Perimeter Dr., Suite 210, Scottsdale, AZ 85255 (the "Company"), and ONE44 CAPITAL LLC, a New York limited liability company, with its address at 1249 Broadway, Suite 103, Hewlett, NY 11557 (the "Buyer").

GS Acquisition Holdings Corp – GS Acquisition Holdings Corp (May 25th, 2018)

This letter agreement by and between GS Acquisition Holdings Corp (the Company) and Goldman Sachs Asset Management, L.P., a Delaware limited partnership (GSAM), dated as of the date hereof, will confirm our agreement that, commencing on the date the securities of the Company are first listed on the New York Stock Exchange (the Listing Date) and continuing until the earlier of the consummation by the Company of an initial business combination and the Companys liquidation (in each case as described in the Registration Statement on Form S-1 (File No. 333-225035) filed with the Securities and Exchange Commission) (such earlier date hereinafter referred to as the Termination Date):

American Liberty Petroleum Corp. – Termination and General Release Agreement (May 25th, 2018)

THIS TERMINATION AND GENERAL RELEASE AGREEMENT (this "Agreement") is made and entered into as of May 25, 2018 (the "Effective Date") by and between (i) Avant Diagnostics, Inc. (the "Company"), and (ii) ________________ ("Investor").